HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes.

Abstract
A series of seven platinum(II) cyclobutane-1,1-dicarboxylato (cbdc) complexes {[Pt(cbdc)(L(n))(2)], 1-7}, derived from carboplatin by a substitution of two NH(3) molecules for two 2,6,9-trisubstituted 6-benzylaminopurine-based N-donor ligands (L(n)), was studied by the MTT assay for their in vitro cytotoxic activity against seven human cancer cell lines, i.e. lung carcinoma (A549), cervix epithelioid carcinoma (HeLa), osteosarcoma (HOS), malignant melanoma (G361), breast adenocarcinoma (MCF7), ovarian carcinoma (A2780) and its cisplatin-resistant analogue (A2780cis), and against two primary cultures of human hepatocytes (LH31 and LH32). The prepared complexes were cytotoxic against several cancer cells, in some cases even more than cisplatin. The best results were achieved for complexes 1 (IC(50)=17.4 ± 2.0 μM) and 2 (IC(50)=14.8 ± 2.1 μΜ) against HOS cells, 1 (IC(50)=15.1 ± 6.8 μM), 2 (IC(50)=13.6 ± 5.2 μM) and 6 (IC(50)=19.0 ± 6.6 μM) against MCF7, 6 (IC(50)=6.4 ± 0.1 μM) against A2780, and 1-6 (IC(50)=15.6 ± 4.0, 12.9 ± 3.7, 15.8 ± 3.8, 16.6 ± 5.5, 22.1 ± 2.5, and 5.6 ± 1.7 μM, respectively) against A2780cis. Viability of human hepatocytes was not declined by the tested complexes up to the concentration of 50 μM (for 1, 3-7) and 20 μM (for 2; caused by lower solubility of this complex).
AuthorsZdeněk Dvořák, Pavel Starha, Zdeněk Trávníček
JournalToxicology in vitro : an international journal published in association with BIBRA (Toxicol In Vitro) Vol. 25 Issue 3 Pg. 652-6 (Apr 2011) ISSN: 1879-3177 [Electronic] England
PMID21232594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Benzyl Compounds
  • Organoplatinum Compounds
  • Purines
  • Oxaliplatin
  • Carboplatin
  • benzylaminopurine
  • Kinetin
  • Cisplatin
Topics
  • Adult
  • Antineoplastic Agents (pharmacology)
  • Benzyl Compounds
  • Carboplatin (analogs & derivatives, chemistry, pharmacology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Cisplatin (pharmacology)
  • Drug Screening Assays, Antitumor
  • Female
  • Hepatocytes (drug effects, metabolism, pathology)
  • Humans
  • Kinetin (chemistry, pharmacology)
  • Male
  • Neoplasms (drug therapy, metabolism, pathology)
  • Organoplatinum Compounds (chemical synthesis, pharmacology)
  • Oxaliplatin
  • Purines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: